CHRISTY JOHNSON: Open Payments
NPI 1336752088 · SECTION, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 23 payments from 7 companies in 2025. Trend: 2023 $238 · 2024 $274 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $182 |
| Ferring Pharmaceuticals Inc. | 1 | $118 |
| Abbott Laboratories | 2 | $31 |
| Amgen Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ADSTILADRIN, VRAYLAR, QULIPTA, UBRELVY, FREESTYLE LIBRE 3, OTEZLA, Dexcom G6 Transmitter, Ozempic.
Industry payments across AL — which companies pay providers there.
